Solvay Pharmaceuticals Sponsors a Book on Parkinson's Disease
17 January 2008
ScopeMedical has published a Solvay Pharmaceuticals-sponsored educational handbook 'Managing advanced Parkinson's disease: the role of continuous dopaminergic stimulation'. By developing a book in partnership with an international panel of specialists and distinguished guest editors, this important and interesting publication has enabled Solvay to promote their commitment to clinical development in Parkinson's disease (PD).
The book has an attractive A5 hardback format and summarises the pertinent elements of current research in Parkinson's disease with a focus on optimal treatment in advanced stages of the disease. Comprehensive contributions by leading experts in the field cover important topics such as clinical efficacy, safety and cost effectiveness of treatment. Moreover, this exciting text provides the opportunity to update the actual scientific knowledge in how to handle late stages of PD patients and offers an opportunity to get in touch with the expertise of eminent and influential key opinion leaders.
